KARLA URGILEZ: Open Payments
NPI 1023849239 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 54 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $315 |
| PFIZER INC. | 9 | $168 |
| Teva Pharmaceuticals USA, Inc. | 5 | $127 |
| Neurelis, Inc. | 5 | $99 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $86 |
| Amgen Inc. | 2 | $60 |
| Genentech USA, Inc. | 2 | $50 |
| Celgene Corporation | 3 | $49 |
| Lundbeck LLC | 2 | $48 |
Products named: UBRELVY, QULIPTA, VALTOCO, NURTEC ODT, Symbravo, INGREZZA, AUSTEDO XR, ELIQUIS.
Industry payments across MD — which companies pay providers there.
